Cargando…

Promises and perils of the FDA's over-the-counter naloxone reclassification

Detalles Bibliográficos
Autores principales:	Zhu, David T., Tamang, Suzanne, Humphreys, Keith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366474/ https://www.ncbi.nlm.nih.gov/pubmed/37497396 http://dx.doi.org/10.1016/j.lana.2023.100518

Ejemplares similares

Digital mental health for postpartum women: perils, pitfalls, and promise
por: Feldman, Natalie, et al.
Publicado: (2023)

Considering the Potential Benefits of Over-the-Counter Naloxone
por: Evoy, Kirk E, et al.
Publicado: (2021)

Political and institutional perils of Brazil's COVID-19 crisis
por: Barberia, Lorena G, et al.
Publicado: (2020)

The perils of misinformation: when health literacy goes awry
por: Schulz, Peter J., et al.
Publicado: (2022)

Will converting naloxone to over‐the‐counter status increase pharmacy sales?
por: Murphy, Sean M., et al.
Publicado: (2019)

Is ‘likely pathogenic’ really 90% likely? Reclassification data in ClinVar
por: Harrison, Steven M., et al.
Publicado: (2019)

COVID-19 pandemic reveals the peril of ignoring metadata standards
por: Schriml, Lynn M., et al.
Publicado: (2020)

Medicine reclassification processes and regulations for proper use of over-the-counter self-care medicines in Japan
por: Nomura, Kaori, et al.
Publicado: (2016)

The promises and perils of the neuroscience of creativity
por: Abraham, Anna
Publicado: (2013)

Moral outrage: Promise or peril?
por: Rushton, Cynda Hylton, et al.
Publicado: (2020)

The promise and peril of health systems
por: Kronick, Richard
Publicado: (2020)

Digital Health: The Promise and Peril
por: Superina, Stefan, et al.
Publicado: (2022)

Perils and promise of online exams
por: Schultz, Madeleine, et al.
Publicado: (2022)

The promise and peril of universal health care
por: Bloom, David E., et al.
Publicado: (2018)

Response to “Considering the Potential Benefits of Over-the-Counter Naloxone” by Evoy et al [Letter]
por: Fuehrlein, Brian
Publicado: (2021)

Cyclooxygenase-2 inhibitors: promise or peril?
por: Mengle-Gaw, Laurel J, et al.
Publicado: (2002)

The promise and perils of HDAC inhibitors in neurodegeneration
por: Didonna, Alessandro, et al.
Publicado: (2015)

The promise and peril of sexual harassment programs
por: Dobbin, Frank, et al.
Publicado: (2019)

Digital health promotion: promise and peril
por: Koh, Amanda, et al.
Publicado: (2021)

Promise and Perils of Telehealth in the Current Era
por: Mahtta, Dhruv, et al.
Publicado: (2021)

Hybrid working in radiology: the promise and the perils
por: Nicholson, Patrick
Publicado: (2022)

Advancing digital health: FDA innovation during COVID-19
por: Kadakia, Kushal, et al.
Publicado: (2020)

Reply to Letter to the Editor Regarding Article: “Considering the Potential Benefits of Over-The-Counter Naloxone” [Response To Letter]
por: Evoy, Kirk E, et al.
Publicado: (2021)

The Promise and Peril of Genomic Screening in the General Population
por: Adams, Michael C., et al.
Publicado: (2015)

Problematising reality: the promises and perils of synthetic media
por: Kalpokas, Ignas
Publicado: (2020)

Perils and Promises of Pathogenic Protozoan Extracellular Vesicles
por: Olajide, Joshua Seun, et al.
Publicado: (2020)

Telemedicine and Team-Based Care: The Perils and the Promise
por: Sinsky, Christine A., et al.
Publicado: (2021)

FDA guidance for next generation sequencing-based testing: balancing regulation and innovation in precision medicine
por: Luh, Frank, et al.
Publicado: (2018)

Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
por: Issa, Amalia M., et al.
Publicado: (2018)

Right data for right patient—a precisionFDA NCI–CPTAC Multi-omics Mislabeling Challenge
por: Boja, Emily, et al.
Publicado: (2018)

The promise and potential peril of at-home oral cancer testing
por: Lingen, Mark W.
Publicado: (2023)

The promises and perils of remote proctoring using artificial intelligence
por: Lee, Ann S, et al.
Publicado: (2023)

ChatGPT for scientific paper writing—promises and perils
por: He, Shijun, et al.
Publicado: (2023)

Measuring effectiveness of drugs in observational databanks: promises and perils
por: Krishnan, Eswar, et al.
Publicado: (2004)

Regenerative medicine: the promises and perils of a Promethean task
por: Moldovan, Nicanor I
Publicado: (2010)

Anti-infective monoclonal antibodies: perils and promise of development
por: Reichert, Janice M., et al.
Publicado: (2006)

The promises and perils of populism for democratic policymaking: the case of Mexico
por: Dussauge-Laguna, Mauricio I.
Publicado: (2022)

Effect of Naloxon on Counter Insulin Hormone Secretion in Insulin-Induced Hypoglycemia
por: Ju, Yeong Shil, et al.
Publicado: (1987)

The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection
por: Rajaram, Sanjeeth, et al.
Publicado: (2020)

Delivering on the promise of early detection with liquid biopsies
por: Crosby, David
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s45gt5s246rbb9otsi7seua2om